Efficacy of Vildagliptin Added to Continuous Subcutaneous Insulin Infusion (CSII) in Hospitalized Patients with Type 2 Diabetes

INTRODUCTION: The aim of this study was to compare the efficacy of vildagliptin as add-on therapy to short-term continuous subcutaneous insulin infusion (CSII) with CSII monotherapy in hospitalized patients with type 2 diabetes mellitus (T2DM). METHODS: A total of 200 hospitalized patients with inad...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Diabetes Ther
Autors principals: Lyu, Fu-ping, Huang, Bing-kun, Su, Wei-juan, Yan, Fang-fang, Zeng, Jin-yang, Chen, Zheng, Zhang, Yu-xian, Wang, Shun-hua, Huang, Yin-xiang, Zhang, Mu-lin, Shi, Xiu-lin, Lin, Ming-zhu, Li, Xue-jun
Format: Artigo
Idioma:Inglês
Publicat: Springer Healthcare 2020
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7048888/
https://ncbi.nlm.nih.gov/pubmed/32020552
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-020-00758-5
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars